How to buy Cano Health (CANO) stock

Healthcare provider Cano Health went public June 4 through a merger with Jaws Acquisition Corp, a special purpose acquisition company (SPAC), also known as a blank check company.

The company operates as Cano Health and is listed on the New York Stock Exchange as CANO.

Cano Health stock price (NYSE: CANO)

Use our graph to track the performance of CANO stocks over time.

Cano Health shares at a glance

• Key figures

Information last updated 2021-07-15.

52-week range	$9.95 - $16.95
50-day moving average	$13.53
200-day moving average	$13.72
Wall St. target price	$22.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.55

Buy Cano Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Cano Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Cano Health, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Cano Health under- or over-valued?

Valuing Cano Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cano Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cano Health's EBITDA

Cano Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $52.4 million.

The EBITDA is a measure of a Cano Health's overall financial performance and is widely used to measure a its profitability.

To put Cano Health's EBITDA into context you can compare it against that of similar companies.

• Teladoc Health (TDOC.US): USD$18.8 million
• Vertex Pharmaceuticals Incorporated (VRTX.US): USD$3.1 billion
• Humana (HUM.US): USD$5.4 billion

Cano Health financials

Revenue TTM	$644.5 million
Operating margin TTM	5.77%
Gross profit TTM	$80.3 million
Return on assets TTM	0%
Return on equity TTM	-1689.38%
Profit margin	-3.6%
Book value	N/A
Market capitalisation	$5.2 billion

TTM: trailing 12 months

Shorting Cano Health shares

There are currently 8.8 million Cano Health shares held short by investors – that's known as Cano Health's "short interest". This figure is up from 0 last month.

There are a few different ways that this level of interest in shorting Cano Health shares can be evaluated.

Cano Health's "short interest ratio" (SIR)

Cano Health's "short interest ratio" (SIR) is the quantity of Cano Health shares currently shorted divided by the average quantity of Cano Health shares traded daily (recently around 1.2 million). Cano Health's SIR currently stands at 7.57. In other words for every 100,000 Cano Health shares traded daily on the market, roughly 7570 shares are currently held short.

To gain some more context, you can compare Cano Health's short interest ratio against those of similar companies.

• Teladoc Health (TDOC.US): 6.76
• Vertex Pharmaceuticals Incorporated (VRTX.US): 1.3
• Humana (HUM.US): 1.23

However Cano Health's short interest can also be evaluated against the total number of Cano Health shares, or, against the total number of tradable Cano Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cano Health's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Cano Health shares in existence, roughly 20 shares are currently held short) or 0.0215% of the tradable shares (for every 100,000 tradable Cano Health shares, roughly 22 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cano Health.

Find out more about how you can short Cano Health stock.

Cano Health share dividends

We're not expecting Cano Health to pay a dividend over the next 12 months.

You may also wish to consider:

• Humana (HUM.US) (0.56% forward annual dividend yield)

Cano Health overview

Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management. Cano Health, LLC was founded in 2009 and is based in Miami, Florida. .

Frequently asked questions

What percentage of Cano Health is owned by insiders or institutions?
Currently 13.258% of Cano Health shares are held by insiders and 41.972% by institutions. When does the fiscal year end for Cano Health?
Cano Health's fiscal year ends in December. Where is Cano Health based?
Cano Health's address is: 9725 NW 117 Avenue, Miami, FL, United States, 33178